Alvogen, Inc 2023-03-08 Health serious FDA
Health · FDA · Recall #FDA-D-0353-2023
Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured… Recall
Issued March 8, 2023 · Alvogen, Inc
In March 2023, Alvogen, Inc recalled the Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Sub-Potent Drug: Out of specification for assay at the 24 month interval.
What you should do
- 1 Stop using Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Alvogen, Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Alvogen, Inc
- Category
- Health
- Recall date
- March 8, 2023
- Units affected
- Not reported
- Sold at
- Nationwide and Puerto Rico.
- Recall number
- FDA-D-0353-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Alvogen, Inc has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.